Please enable JavaScript to continue using this application.

Compare $MEDP vs $RGEN | Chartloom

Compare

$MEDP vs $RGEN

Medpace Holdings Inc · Repligen Corp

MEDP

Medpace Holdings Inc

RGEN

Repligen Corp

Compare $MEDP vs $RGEN

Comparing Medpace Holdings Inc and Repligen Corp

MEDPMedpace Holdings Inc

RGENRepligen Corp

MEDPMedpace Holdings Inc

Market cap

$17.08B

P/E (TTM)

35.56x

Forward P/E (NTM)

32.69x

Forward P/S (NTM)

5.76x

Rev growth (TTM)

24.7%

YTD performance

7.2%

52W performance

15.3%

FCF yield

4.1%

RGENRepligen Corp

Market cap

$9.81B

P/E (TTM)

237.08x

Forward P/E (NTM)

75.08x

Forward P/S (NTM)

10.82x

Rev growth (TTM)

16.5%

YTD performance

5.8%

52W performance

15.3%

FCF yield

1.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MEDP

RGEN

Detailed metrics comparison

MEDP

Medpace Holdings Inc

RGEN

Repligen Corp

Market Cap

MEDP$17.08B

RGEN$9.81B

Enterprise Value

MEDP$16.58B

RGEN$9.76B

Price

MEDP$612.05

RGEN$173.88

P/E Ratio

MEDP35.56x

RGEN237.08x

P/S Ratio

MEDP6.14x

RGEN12.50x

EV/Sales

MEDP5.96x

RGEN12.43x

EV/EBITDA

MEDP27.13x

RGEN64.73x

P/B Ratio

MEDP38.57x

RGEN4.86x

P/FCF Ratio

MEDP24.17x

RGEN89.09x

EV/FCF

MEDP23.46x

RGEN88.59x

PEG Ratio

MEDP2.97x

RGEN11.27x

Forward P/E (NTM)

MEDP32.69x

RGEN75.08x

Forward P/S (NTM)

MEDP5.76x

RGEN10.82x

Revenue (TTM)

MEDP$2.78B

RGEN$785M

Revenue Growth (YoY)

MEDP24.7%

RGEN16.5%

Forward Rev Growth

MEDP6.2%

RGEN17.6%

Gross Margin (TTM)

MEDP28.8%

RGEN53.8%

Operating Margin (TTM)

MEDP21.0%

RGEN6.5%

EBITDA Margin (TTM)

MEDP22.0%

RGEN18.8%

Net Margin (TTM)

MEDP17.7%

RGEN5.3%

FCF Margin (TTM)

MEDP25.4%

RGEN14.0%

Net Income (TTM)

MEDP$492M

RGEN$42M

FCF (TTM)

MEDP$707M

RGEN$110M

EPS (TTM)

MEDP$17.21

RGEN$0.73

ROE (TTM)

MEDP110.1%

RGEN2.0%

ROA (TTM)

MEDP24.8%

RGEN1.4%

ROIC (TTM)

MEDP110.1%

RGEN1.6%

Cash

MEDP$503M

RGEN$607M

Debt

MEDP$0

RGEN$551M

Net Cash/Debt

MEDP$503M

RGEN$56M

Current Ratio (TTM)

MEDP0.73x

RGEN9.05x

Quick Ratio (TTM)

MEDP0.66x

RGEN7.30x

Debt/Equity (TTM)

MEDP0.00x

RGEN0.26x

Debt/Assets (TTM)

MEDP0.0%

RGEN0.0%

Interest Coverage (TTM)

MEDPN/A

RGENN/A

Net Debt/EBITDA (TTM)

MEDP0.00x

RGEN0.00x

Beta

MEDP1.11

RGEN1.13

52W Performance

MEDP15.3%

RGEN15.3%

YTD Performance

MEDP7.2%

RGEN5.8%

% from 52W High

MEDP-9.7%

RGEN-12.6%

% from 52W Low

MEDP64.1%

RGEN72.2%

Asset Turnover (TTM)

MEDP1.41x

RGEN0.27x

FCF Yield (TTM)

MEDP4.1%

RGEN1.1%

Earnings Yield (TTM)

MEDP2.9%

RGEN0.4%

Dividend Yield (TTM)

MEDPN/A

RGENN/A

Rule of 40

MEDP50.1

RGEN30.5

EV/GP/RG

MEDP3.15

RGEN1.46

Ticker research

View MEDP research View RGEN research

Metric	MEDP Medpace Holdings Inc	RGEN Repligen Corp
Market & Valuation
Market Cap	$17.08B	$9.81B
Enterprise Value	$16.58B	$9.76B
Price	$612.05	$173.88
P/E Ratio	35.56x	237.08x
P/S Ratio	6.14x	12.50x
EV/Sales	5.96x	12.43x
EV/EBITDA	27.13x	64.73x
P/B Ratio	38.57x	4.86x
P/FCF Ratio	24.17x	89.09x
EV/FCF	23.46x	88.59x
PEG Ratio	2.97x	11.27x
Forward P/E (NTM)	32.69x	75.08x
Forward P/S (NTM)	5.76x	10.82x
Revenue & Growth
Revenue (TTM)	$2.78B	$785M
Revenue Growth (YoY)	24.7%	16.5%
Forward Rev Growth	6.2%	17.6%
Profitability
Gross Margin (TTM)	28.8%	53.8%
Operating Margin (TTM)	21.0%	6.5%
EBITDA Margin (TTM)	22.0%	18.8%
Net Margin (TTM)	17.7%	5.3%
FCF Margin (TTM)	25.4%	14.0%
Net Income (TTM)	$492M	$42M
FCF (TTM)	$707M	$110M
EPS (TTM)	$17.21	$0.73
ROE (TTM)	110.1%	2.0%
ROA (TTM)	24.8%	1.4%
ROIC (TTM)	110.1%	1.6%
Financial Health
Cash	$503M	$607M
Debt	$0	$551M
Net Cash/Debt	$503M	$56M
Current Ratio (TTM)	0.73x	9.05x
Quick Ratio (TTM)	0.66x	7.30x
Debt/Equity (TTM)	0.00x	0.26x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.11	1.13
52W Performance	15.3%	15.3%
YTD Performance	7.2%	5.8%
% from 52W High	-9.7%	-12.6%
% from 52W Low	64.1%	72.2%
Efficiency & Yields
Asset Turnover (TTM)	1.41x	0.27x
FCF Yield (TTM)	4.1%	1.1%
Earnings Yield (TTM)	2.9%	0.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	50.1	30.5
EV/GP/RG	3.15	1.46
Ticker research	View MEDP research	View RGEN research

Valuation

P/E Ratio

MEDP

35.56x

RGEN

237.08x

P/S Ratio

MEDP

6.14x

RGEN

12.50x

EV/FCF

MEDP

23.46x

RGEN

88.59x

Growth & revenue

Revenue Growth TTM

MEDP

24.7%

RGEN

16.5%

Forward Revenue Growth

RGEN

17.6%

MEDP

6.2%

Profitability & performance

Gross Margin

RGEN

53.8%

MEDP

28.8%

ROE

MEDP

110.1%

RGEN

2.0%

FCF Yield %

MEDP

4.1%

RGEN

1.1%

52-Week Performance

RGEN

15.3%

MEDP

15.3%

Detailed metrics comparison

MEDP

Medpace Holdings Inc

RGEN

Repligen Corp

Market Cap

MEDP$17.08B

RGEN$9.81B

Enterprise Value

MEDP$16.58B

RGEN$9.76B

Price

MEDP$612.05

RGEN$173.88

P/E Ratio

MEDP35.56x

RGEN237.08x

P/S Ratio

MEDP6.14x

RGEN12.50x

EV/Sales

MEDP5.96x

RGEN12.43x

EV/EBITDA

MEDP27.13x

RGEN64.73x

P/B Ratio

MEDP38.57x

RGEN4.86x

P/FCF Ratio

MEDP24.17x

RGEN89.09x

EV/FCF

MEDP23.46x

RGEN88.59x

PEG Ratio

MEDP2.97x

RGEN11.27x

Forward P/E (NTM)

MEDP32.69x

RGEN75.08x

Forward P/S (NTM)

MEDP5.76x

RGEN10.82x

Revenue (TTM)

MEDP$2.78B

RGEN$785M

Revenue Growth (YoY)

MEDP24.7%

RGEN16.5%

Forward Rev Growth

MEDP6.2%

RGEN17.6%

Gross Margin (TTM)

MEDP28.8%

RGEN53.8%

Operating Margin (TTM)

MEDP21.0%

RGEN6.5%

EBITDA Margin (TTM)

MEDP22.0%

RGEN18.8%

Net Margin (TTM)

MEDP17.7%

RGEN5.3%

FCF Margin (TTM)

MEDP25.4%

RGEN14.0%

Net Income (TTM)

MEDP$492M

RGEN$42M

FCF (TTM)

MEDP$707M

RGEN$110M

EPS (TTM)

MEDP$17.21

RGEN$0.73

ROE (TTM)

MEDP110.1%

RGEN2.0%

ROA (TTM)

MEDP24.8%

RGEN1.4%

ROIC (TTM)

MEDP110.1%

RGEN1.6%

Cash

MEDP$503M

RGEN$607M

Debt

MEDP$0

RGEN$551M

Net Cash/Debt

MEDP$503M

RGEN$56M

Current Ratio (TTM)

MEDP0.73x

RGEN9.05x

Quick Ratio (TTM)

MEDP0.66x

RGEN7.30x

Debt/Equity (TTM)

MEDP0.00x

RGEN0.26x

Debt/Assets (TTM)

MEDP0.0%

RGEN0.0%

Interest Coverage (TTM)

MEDPN/A

RGENN/A

Net Debt/EBITDA (TTM)

MEDP0.00x

RGEN0.00x

Beta

MEDP1.11

RGEN1.13

52W Performance

MEDP15.3%

RGEN15.3%

YTD Performance

MEDP7.2%

RGEN5.8%

% from 52W High

MEDP-9.7%

RGEN-12.6%

% from 52W Low

MEDP64.1%

RGEN72.2%

Asset Turnover (TTM)

MEDP1.41x

RGEN0.27x

FCF Yield (TTM)

MEDP4.1%

RGEN1.1%

Earnings Yield (TTM)

MEDP2.9%

RGEN0.4%

Dividend Yield (TTM)

MEDPN/A

RGENN/A

Rule of 40

MEDP50.1

RGEN30.5

EV/GP/RG

MEDP3.15

RGEN1.46

Ticker research

View MEDP research View RGEN research

Metric	MEDP Medpace Holdings Inc	RGEN Repligen Corp
Market & Valuation
Market Cap	$17.08B	$9.81B
Enterprise Value	$16.58B	$9.76B
Price	$612.05	$173.88
P/E Ratio	35.56x	237.08x
P/S Ratio	6.14x	12.50x
EV/Sales	5.96x	12.43x
EV/EBITDA	27.13x	64.73x
P/B Ratio	38.57x	4.86x
P/FCF Ratio	24.17x	89.09x
EV/FCF	23.46x	88.59x
PEG Ratio	2.97x	11.27x
Forward P/E (NTM)	32.69x	75.08x
Forward P/S (NTM)	5.76x	10.82x
Revenue & Growth
Revenue (TTM)	$2.78B	$785M
Revenue Growth (YoY)	24.7%	16.5%
Forward Rev Growth	6.2%	17.6%
Profitability
Gross Margin (TTM)	28.8%	53.8%
Operating Margin (TTM)	21.0%	6.5%
EBITDA Margin (TTM)	22.0%	18.8%
Net Margin (TTM)	17.7%	5.3%
FCF Margin (TTM)	25.4%	14.0%
Net Income (TTM)	$492M	$42M
FCF (TTM)	$707M	$110M
EPS (TTM)	$17.21	$0.73
ROE (TTM)	110.1%	2.0%
ROA (TTM)	24.8%	1.4%
ROIC (TTM)	110.1%	1.6%
Financial Health
Cash	$503M	$607M
Debt	$0	$551M
Net Cash/Debt	$503M	$56M
Current Ratio (TTM)	0.73x	9.05x
Quick Ratio (TTM)	0.66x	7.30x
Debt/Equity (TTM)	0.00x	0.26x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.11	1.13
52W Performance	15.3%	15.3%
YTD Performance	7.2%	5.8%
% from 52W High	-9.7%	-12.6%
% from 52W Low	64.1%	72.2%
Efficiency & Yields
Asset Turnover (TTM)	1.41x	0.27x
FCF Yield (TTM)	4.1%	1.1%
Earnings Yield (TTM)	2.9%	0.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	50.1	30.5
EV/GP/RG	3.15	1.46
Ticker research	View MEDP research	View RGEN research